Highly Malignant Behavior of a Murine Oligodendrocyte Precursor Cell Line Following Transplantation into the Demyelinated and Nondemyelinated Central Nervous System

Cell Transplantation

Volumn 21, Issue 6, 2012, Pages 1161-1175

  Hansmann, Florian ^a,b   Pringproa, Kidsadagon ^a,b   Ulrich, Reiner ^a,b   Sun, Yanyong ^a,b   Herder, Vanessa ^a,b   Kreutzer, Mihaela ^a,b   Baumgärtner, Wolfgang ^a,b   Wewetzer, Konstantin ^a,b,c  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b Centre for Systems Neuroscience Hannover   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Caudal cerebellar peduncle; Murine giant cell glioblastoma; Oligodendrocyte precursor cell; Signal transducer and activator of transcription 3; Transplantation

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; ETHIDIUM BROMIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN BASIC PROTEIN; NERVE GLIAL ANTIGEN 2; NEUROFILAMENT PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN P53; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOSIS; BRAIN STEM; CARCINOGENESIS; CELL INVASION; CELL LINE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DEMYELINATION; EXPERIMENTAL MODEL; GIANT CELL TUMOR; GLIOBLASTOMA; IMMUNOHISTOCHEMISTRY; INFERIOR CEREBELLAR PEDUNCLE; MALE; METASTASIS; MICROSCOPY; MOUSE; NERVE CELL DIFFERENTIATION; NERVE FIBER DEGENERATION; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION;

ANIMALS; ANTIGENS; CELL DIFFERENTIATION; CELL LINE; DEMYELINATING DISEASES; ETHIDIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MYELIN SHEATH; OLIGODENDROGLIA; PROTEOGLYCANS; RATS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; STAT3 TRANSCRIPTION FACTOR;

MURINAE; RATTUS;

EID: 84864599765     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X627444     Document Type: Article

References (74)

1. Assanah, M.; Lochhead, R.; Ogden, A.; Bruce, J.; Goldman, J.; Canoll, P. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J. Neurosci. 26(25):6781-6790; 2006.
2. Barrie, J. A.; Montague, P.; Karim, S.; Kirkham, D.; Nave, K. A.; Anderson, T. J.; Griffiths, I. R.; McLaughlin, M. Modulation of rumpshaker phenotype with wild-type PLP/DM20 suggests several pathogenic mechanisms. J. Neurosci. Res. 88(10):2135-2145; 2010.
3. Bettelli, E. Building different mouse models for human MS. Ann. NY Acad. Sci. 1103:11-18; 2007.
4. Blakemore, W. F.; Franklin, R. J. Transplantation options for therapeutic central nervous system remyelination. Cell Transplant. 9(2):289-294; 2000.
5. Blakemore, W. F.; Gilson, J. M.; Crang, A. J. The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exp. Neurol. 184(2):955-963; 2003.
6. Bongarzone, E. R.; Byravan, S.; Givogri, M. I.; Schonmann, V.; Campagnoni, A. T. Platelet-derived growth factor and basic fibroblast growth factor regulate cell proliferation and the expression of notch-1 receptor in a new oligodendrocyte cell line. J. Neurosci. Res. 62(3): 319-328; 2000.
7. Brantley, E. C.; Benveniste, E. N. Signal transducer and activator of transcription-3: A molecular hub for signaling pathways in gliomas. Mol. Cancer Res. 6(5):675-684; 2008.
8. Calzolari, F.; Malatesta, P. Recent insights into PDGF-induced gliomagenesis. Brain Pathol. 20(3):527-538; 2010.
9. Canoll, P.; Goldman, J. E. The interface between glial progenitors and gliomas. Acta Neuropathol. 116(5):465-477; 2008.
10. Chen, L.; Huang, H.; Xi, H.; Xie, Z.; Liu, R.; Jiang, Z.; Zhang, F.; Liu, Y.; Chen, D.; Wang, Q.; Wang, H.; Ren, Y.; Zhou, C. Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: A randomized controlled clinical trial. Cell Transplant. 19(2):185-191; 2010.
11. Chen, S. Y.; Huang, Y. C.; Liu, S. P.; Tsai, F. J.; Shyu, W. C.; Lin, S. Z. An overview of concepts for cancer stem cells. Cell Transplant. 20(1):113-120; 2011.
12. Chen, Y.; Balasubramaniyan, V.; Peng, J.; Hurlock, E. C.; Tallquist, M.; Li, J.; Lu, Q. R. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat. Protoc. 2(5):1044-1051; 2007.
13. Deighton, R. F.; McGregor, R.; Kemp, J.; McCulloch, J.; Whittle, I. R. Glioma pathophysiology: Insights emerging from proteomics. Brain Pathol. 20(4):691-703; 2010.
14. de la Iglesia, N.; Puram, S. V.; Bonni, A. STAT3 regulation of glioblastoma pathogenesis. Curr. Mol. Med. 9(5): 580-590; 2009.
15. Dimou, L.; Klugmann, M.; Werner, H.; Jung, M.; Griffiths, I. R.; Nave, K. A. Dysmyelination in mice and the proteolipid protein gene family. Adv. Exp. Med. Biol. 468:261-271; 1999.
16. Duncan, I. D.; Milward, E. A. Glial cell transplants: Experimental therapies of myelin diseases. Brain Pathol. 5(3):301-310; 1995.
17. Edgar, J. M.; McCulloch, M. C.; Montague, P.; Brown, A. M.; Thilemann, S.; Pratola, L.; Gruenenfelder, F. I.; Griffiths, I. R.; Nave, K. A. Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol. Med. 2(2):42-50; 2010.
18. Emery, E.; Li, X.; Brunschwig, J. P.; Olson, L.; Levi, A. D. Assessment of the malignant potential of mitogen stimulated human Schwann cells. J. Peripher. Nerv. Syst. 4(2):107-116; 1999.
19. Franklin, R. J. Remyelination of the demyelinated CNS: The case for and against transplantation of central, peripheral and olfactory glia. Brain Res. Bull. 57(6):827-832; 2002.
20. Franklin, R. J.; Bayley, S. A.; Blakemore, W. F. Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord. Exp. Neurol. 137(2):263-276; 1996.
21. Franklin, R. J.; Bayley, S. A.; Milner, R.; Ffrench-Constant, C.; Blakemore, W. F. Differentiation of the O2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter. Glia 13(1):39-44; 1995.
22. Franklin, R. J.; Ffrench-Constant, C. Remyelination in the CNS: From biology to therapy. Nat. Rev. Neurosci. 9(11): 839-855; 2008.
23. Franklin, R. J. M. Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 3(9):705-714; 2002.
24. Griffiths, I. R. Myelin mutants: Model systems for the study of normal and abnormal myelination. Bioessays 18(10):789-797; 1996.
25. Groves, A. K.; Barnett, S. C.; Franklin, R. J.; Crang, A. J.; Mayer, M.; Blakemore, W. F.; Noble, M. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362(6419):453-455; 1993.
26. Hadfield, M. G.; Silverberg, S. G. Light and electron microscopy of giant-cell glioblastoma. Cancer 30(4):989-996; 1972.
27. Hassapoglidou, S.; Diamandis, E. P. Antibodies to the p53 tumor suppressor gene product quantified in cancer patient serum with a time-resolved immunofluorometric technique. Clin. Biochem. 25(6):445-449; 1992.
28. He, F.; Ge, W.; Martinowich, K.; Becker-Catania, S.; Coskun, V.; Zhu, W.; Wu, H.; Castro, D.; Guillemot, F.; Fan, G.; de Vellis, J.; Sun, Y. E. A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat. Neurosci. 8(5):616-625; 2005.
29. Herrmann, J. E.; Imura, T.; Song, B.; Qi, J.; Ao, Y.; Nguyen, T. K.; Korsak, R. A.; Takeda, K.; Akira, S.; Sofroniew, M. V. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28(28):7231-7243; 2008.
30. Horiuchi, M.; Tomooka, Y. An oligodendroglial progenitor cell line FBD-102b possibly secretes a radial glia-inducing factor. Neurosci. Res. 56(2):213-219; 2006.
31. Hunt, D. P.; Irvine, K. A.; Webber, D. J.; Compston, D. A.; Blakemore, W. F.; Chandran, S. Effects of direct transplantation of multipotent mesenchymal stromal/stem cells into the demyelinated spinal cord. Cell Transplant. 17(7):865-873; 2008.
32. Jung, M.; Crang, A. J.; Blakemore, W. F.; Hoppe, D.; Kettenmann, H.; Trotter, J. In vitro and in vivo characterisation of glial cells immortalised with a temperature sensitive SV40 T antigen-containing retrovirus. J. Neurosci. Res. 37(2):182-196; 1994.
33. Kaga, Y.; Shoemaker, W. J.; Furusho, M.; Bryant, M.; Rosenbluth, J.; Pfeiffer, S. E.; Oh, L.; Rasband, M.; Lappe-Siefke, C.; Yu, K.; Ornitz, D. M.; Nave, K. A.; Bansal, R. Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. J. Neurosci. 26(47):12339-12350; 2006.
34. Kleinhues, P.; Burger, P. C.; Aldape, K. D.; Brat, D. J.; Biernat, W.; Bigner, D. D.; Nakazato, Y.; Plate, K. H.; Giangaspero, F.; von Deimling, A.; Ohgaki, H.; Cavenee, W. K. Glioblastoma. In: Louis, D. N.; Ohgaki, H.; Wiestler, O. D.; Cavenee, W. K., eds. WHO classification of tumours of the central nervous system. Lyon, France: International Agency for Research on Cancer; 2007: 33-52.
35. Klugmann, M.; Schwab, M. H.; Puhlhofer, A.; Schneider, A.; Zimmermann, F.; Griffiths, I. R.; Nave, K. A. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18(1):59-70; 1997.
36. Koppel, H.; Pilkington, G. J.; Lantos, P. L. Tumorigenicity of six clones of a cultured neoplastic cell line derived from a spontaneous murine astrocytoma: Morphology and immunocytochemistry of tumours. J. Neurol. Sci. 83(2-3):227-242; 1988.
37. Kuhlmann, T.; Miron, V.; Cui, Q.; Wegner, C.; Antel, J.; Brück, W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131(Pt 7):1749-1758; 2008.
38. Kummerfeld, M.; Meens, J.; Haas, L.; Baumgärtner, W.; Beineke, A. Generation and characterization of a poly-clonal antibody for the detection of Theiler's murine encephalomyelitis virus by light and electron microscopy. J. Virol. Methods 160(1-2):185-188; 2009.
39. Langford, L. A.; Porter, S.; Bunge, R. P. Immortalized rat Schwann cells produce tumours in vivo. J. Neurocytol. 17(4):521-529; 1988.
40. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88(3):323-331; 1997.
41. Li, C.; Trapp, B.; Ludwin, S.; Peterson, A.; Roder, J. Myelin associated glycoprotein modulates glia-axon contact in vivo. J. Neurosci. Res. 51(2):210-217; 1998.
42. Liberski, P. P. The ultrastructure of glial tumors of astrocytic lineage: A review. Folia Neuropathol. 36(3):161-177; 1998.
43. Lin, T.; Xiang, Z.; Cui, L.; Stallcup, W.; Reeves, S. A. New mouse oligodendrocyte precursor (mOP) cells for studies on oligodendrocyte maturation and function. J. Neurosci. Methods 157(2):187-194; 2006.
44. Lorenzetti, D.; Antalffy, B.; Vogel, H.; Noveroske, J.; Armstrong, D.; Justice, M. The neurological mutant quaking (viable) is Parkin deficient. Mamm. Genome 15(3): 210-217; 2004.
45. Louis, J. C.; Magal, E.; Muir, D.; Manthorpe, M.; Varon, S. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J. Neurosci. Res. 31(1):193-204; 1992.
46. Marcus, J.; Popko, B. Galactolipids are molecular determinants of myelin development and axo-glial organization. Biochim. Biophys. Acta 1573(3):406-413; 2002.
47. Mizoguchi, M.; Betensky, R. A.; Batchelor, T. T.; Bernay, D. C.; Louis, D. N.; Nutt, C. L. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: Correlation with EGFR status, tumor grade, and survival. J. Neuropathol. Exp. Neurol. 65(12):1181-1188; 2006.
48. Moreno-Flores, M. T.; Lim, F.; Martin-Bermejo, M. J.; Diaz-Nido, J.; Avila, J.; Wandosell, F. Immortalized olfactory ensheathing glia promote axonal regeneration of rat retinal ganglion neurons. J. Neurochem. 85(4):861-871; 2003.
49. Nave, K. A. Neurological mouse mutants and the genes of myelin. J. Neurosci. Res. 38(6):607-612; 1994.
50. Nishiyama, A.; Komitova, M.; Suzuki, R.; Zhu, X. Polydendrocytes (NG2 cells): Multifunctional cells with lineage plasticity. Nat. Rev. Neurosci. 10(1):9-22; 2009.
51. Nobre, A.; Kalve, I.; Cesnulevicius, K.; Ragancokova, D.; Ratzka, A.; Halfer, N.; Wesemann, M.; Krampfl, K.; Claus, P.; Grothe, C. Characterization and differentiation potential of rat ventral mesencephalic neuronal progenitor cells immortalized with SV40 large T antigen. Cell Tissue Res. 340(1):29-43; 2010.
52. Olby, N. J.; Blakemore, W. F. Reconstruction of the glial environment of a photochemically induced lesion in the rat spinal cord by transplantation of mixed glial cells. J. Neurocytol. 25(8):481-498; 1996.
53. Penderis, J.; Shields, S. A.; Franklin, R. J. M. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 126:1382-1391; 2003.
54. Peters, A. A fourth type of neuroglial cell in the adult central nervous system. J. Neurocytol. 33(3):345-357; 2004.
55. Pilkington, G. J.; Darling, J. L.; Lantos, P. L.; Thomas, D. G. Tumorigenicity of cell lines (VMDk) derived from a spontaneous murine astrocytoma. Histology, fine structure and immunocytochemistry of tumours. J. Neurol. Sci. 71(2-3):145-164; 1985.
56. Pringproa, K.; Kumnok, J.; Ulrich, R.; Baumgärtner, W.; Wewetzer, K. In vitro characterization of a murine oligodendrocyte precursor cell line (BO-1) following spontaneous immortalization. Int. J. Dev. Neurosci. 26(3-4): 283-291; 2008.
57. Pringproa, K.; Rohn, K.; Kummerfeld, M.; Wewetzer, K.; Baumgärtner, W. Theiler's murine encephalomyelitis virus preferentially infects immature stages of the murine oligodendrocyte precursor cell line BO-1 and blocks oligodendrocytic differentiation in vitro. Brain Res. 1327: 24-37; 2010.
58. Radtke, C.; Wewetzer, K.; Reimers, K.; Vogt, P. M. Transplantation of olfactory ensheathing cells as adjunct cell therapy for peripheral nerve injury. Cell Transplant. 20(2):145-152; 2011.
59. Raff, M. C.; Williams, B. P.; Miller, R. H. The in vitro differentiation of a bipotential glial progenitor cell. EMBO J. 3(8):1857-1864; 1984.
60. Richter-Landsberg, C.; Heinrich, M. OLN-93: A new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J. Neurosci. Res. 45(2):161-173; 1996.
61. Russel, D. S.; Rubinstein, L. J. Pathology of tumours of the nervous system. Baltimore, MD: Williams and Wilkins; 1963.
62. Schaefer, L. K.; Menter, D. G.; Schaefer, T. S. Activation of stat3 and stat1 DNA binding and transcriptional activity in human brain tumour cell lines by gp130 cytokines. Cell. Signal. 12(3):143-151; 2000.
63. Talbott, J. F.; Cao, Q.; Enzmann, G. U.; Benton, R. L.; Achim, V.; Cheng, X. X.; Mills, M. D.; Rao, M. S.; Whittemore, S. R. Schwann cell-like differentiation by adult oligodendrocyte precursor cells following engraftment into the demyelinated spinal cord is BMP-dependent. Glia 54(3):147-159; 2006.
64. Timmer, M.; Müller-Ostermeyer, F.; Kloth, V.; Winkler, C.; Grothe, C.; Nikkhah, G. Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts cotransplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms. Exp. Neurol. 187(1):118-136; 2004.
65. Timmer, M.; Robben, S.; Müller-Ostermeyer, F.; Nikkhah, G.; Grothe, C. Axonal regeneration across long gaps in silicone chambers filled with Schwann cells overexpressing high molecular weight FGF-2. Cell Transplant. 12(3): 265-277; 2003.
66. Tontsch, U.; Archer, D. R.; Dubois-Dalcq, M.; Duncan, I. D. Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc. Natl. Acad. Sci. USA 91(24):11616-11620; 1994.
67. Tourbah, A.; Linnington, C.; Bachelin, C.; Avellana-Adalid, V.; Wekerle, H.; Baron-Van Evercooren, A. Inflammation promotes survival and migration of the CG4 oligodendrocyte progenitors transplanted in the spinal cord of both inflammatory and demyelinated EAE rats. J. Neurosci. Res. 50(5):853-861; 1997.
68. Ulrich, R.; Kalkuhl, A.; Deschl, U.; Baumgärtner, W. Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis. J. Cell. Mol. Med. 14(1-2):434-448; 2010.
69. Ulrich, R.; Seeliger, F.; Kreutzer, M.; Germann, P. G.; Baumgärtner, W. Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells. Neuropathol. Appl. Neurobiol. 34(6):603-620; 2008.
70. Walker, V. E.; Morgan, K. T.; Zimmerman, H. M.; Innes, J. R. M. Tumours of the central and peripheral nervous system. In: Turusov, V.; Mohr, U., eds. Pathology of tumours in laboratory animals. Lyon, France: International Agency for research on cancer; 1994:731-776.
71. Wang, G.; Ao, Q.; Gong, K.; Zuo, H.; Gong, Y.; Zhang, X. Synergistic effect of neural stem cells and olfactory ensheathing cells on repair of adult rat spinal cord injury. Cell Transplant. 19(10):1325-1337; 2010.
72. Wewetzer, K.; Kern, N.; Ebel, C.; Radtke, C.; Brandes, G. Phagocytosis of O4+ axonal fragments in vitro by p75 neonatal rat olfactory ensheathing cells. Glia 49(4):577-587; 2005.
73. Woodhoo, A.; Sahni, V.; Gilson, J.; Setzu, A.; Franklin, R. J.; Blakemore, W. F.; Mirsky, R.; Jessen, K. R. Schwann cell precursors: A favourable cell for myelin repair in the Central Nervous System. Brain 130(Pt. 8): 2175-2185; 2007.
74. Woodruff, R. H.; Franklin, R. J. M. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: A comparative study. Glia 25(3):216-228; 1999.